Vanguard Group Inc 180 Life Sciences Corp. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$2.53 - $3.9 $200,725 - $309,418	79,338 Added 7.9%	1,083,744 $2.81 Million
Q4 2021 Feb 14, 2022	BUY	$3.27 - $6.38 $213,632 - $416,811	65,331 Added 6.96%	1,004,406 $3.92 Million
Q3 2021 Nov 12, 2021	BUY	$5.11 - $10.81 $2.8 Million - $5.93 Million	548,815 Added 140.63%	939,075 $5.08 Million
Q2 2021 Aug 13, 2021	BUY	$6.7 - $11.98 $2.61 Million - $4.68 Million	390,260 New	390,260 $3.9 Million

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $61.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.